Centre hospitalier Melun
- Address
- 270 avenue Marc Jacquet, 77000 Melun, France
Centre hospitalier Melun - Critical Care and Complex Disease Research
Centre hospitalier Melun is a clinical research center engaged in advanced therapeutic studies across critical care medicine and complex systemic diseases. The center demonstrates particular expertise in intensive care unit protocols and adaptive trial methodologies, focusing on optimizing patient outcomes in acute and life-threatening conditions.
- Community-acquired pneumonia and acute respiratory tract infections
- Intensive care sedation strategies and delirium management in mechanically ventilated patients
- IgA vasculitis and systemic autoimmune diseases
The center's research portfolio reflects a commitment to evaluating innovative therapeutic interventions, including participation in adaptive platform trials for respiratory infections, comparison of inhaled versus intravenous sedation techniques in critical care settings, and investigation of rituximab-based immunotherapy for rare vasculitic conditions. This diverse approach positions Centre hospitalier Melun at the forefront of evidence-based medicine, contributing to improved treatment protocols for both common acute conditions and rare autoimmune disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 5 therapeutic areas and 15 of 33 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre hospitalier Melun
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Controlled Trial of Glucocorticoids and Rituximab Versus Glucocorticoids and Placebo in Adult IgA Vasculitis Patients | Hospital Foch | Phase IV | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 33 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 2 | Unknown | 2023-09-26 | 2025-07-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.